Harrow Health Inc (NASDAQ:HROW)

12.01
Delayed Data
As of Sep 30
 +0.46 / +3.98%
Today’s Change
5.40
Today|||52-Week Range
13.11
+39.00%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Baum Mark L
Chief Executive Officer
Sale1/20/202271,406$8.33$594.8K+44.90%
Baum Mark L
Chief Executive Officer
Buy1/20/2022125,000$2.40$300.0K+44.90%
Saharek John P
Sale2/19/202225,923$7.87$204.0K+45.60%
Opaleye Management Inc
Buy4/12/202225,000$6.75$168.8K+79.35%
Boll Andrew R
Chief Financial Officer
Sale2/19/202220,605$7.87$162.2K+45.60%
Opaleye Management Inc
Buy4/13/202210,000$6.76$67.6K+78.02%
Opaleye Management Inc
Buy1/28/20225,000$6.89$34.5K+74.93%
Opaleye Management Inc
Buy4/12/20223,557$6.75$24.0K+79.35%
Opaleye Management Inc
Buy4/13/20222,832$6.76$19.1K+78.02%
Opaleye Management Inc
Buy1/28/20221,343$6.89$9.3K+74.93%
Page of 2